SPY464.53+5.56 1.21%
DIA351.23+2.21 0.63%
IXIC15,782.83+291.18 1.88%

--Piper Sandler Adjusts iTeos Therapeutics' Price Target to $42 From $50, Reiterates Overweight Rating

MT Newswires · 11/11/2021 05:43

Please log in to view news